Related Experiment Video
Updated: Aug 11, 2026

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Immunogenetics of inflammatory bowel disease
Minerva Gastroenterologica E Dietologica
|February 25, 2006
Summary
This study links specific human leukocyte antigen (HLA) types, particularly HLA-DR2 and HLA-DR7, to inflammatory bowel disease (IBD). These genetic factors may influence immune system regulation in IBD patients.
Area of Science:
- Immunogenetics
- Gastroenterology
- Autoimmune Diseases
Background:
- Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is investigated for its autoimmune origins.
- Concomitant autoimmune conditions are frequently observed in IBD patients, suggesting a shared immunogenetic basis.
Purpose of the Study:
- To confirm the autoimmune etiology of IBD.
- To elucidate the immunogenetic underpinnings of IBD through HLA antigen association.
Main Methods:
- Human leukocyte antigen (HLA) Class I (A, B, C) and Class II (DR, DQ) typing was performed on 18 IBD patients using conventional serologic methods.
- Allele frequencies were compared to normal controls using the chi-square test.
- Immune function and laboratory tests were conducted to identify associated autoimmune conditions.
Main Results:
- A significant increase in HLA-DR2 (50.0%) and HLA-DR7 (44.4%) antigen frequencies was observed in IBD patients compared to controls.
- HLA-DR7 association with IBD mirrors findings in primary celiac disease.
- High frequencies of cell-mediated (62.5%) and humoral (88.8%) immunity anomalies, decreased complement, and increased immune complexes were correlated with HLA-DR2 and/or HLA-DR7 presence.
Conclusions:
- The study suggests a common immunogenetic basis for UC and CD, as distinct genetic separation was not observed.
- Common HLA Class II genes may predispose individuals to dysregulated immune mechanisms in IBD.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
